Search
 

Watson Buy of Arrow Could Be Rx for NJ

MORRISTOWN, NJ-Watson Pharmaceuticals Inc.'s planned acquisition of Arrow Group may be good news for the state.

By Maria Wood | Updated on June 18, 2009

MORRISTOWN, NJ-Unlike so many of the mergers within its bedrock pharmaceutical base, Watson Pharmaceutical Inc.’s planned acquisition of privately held Arrow Group for nearly $1.8 billion could be good news for the state. The deal, announced yesterday, is expected to close in the second half of this year.

Watson makes its headquarters in Corona, CA. However, its commercial brand division is based here. According to Cushman & Wakefield, Watson’s occupies 52,000 square feet in the Garden State.

In recent years, the state has witnessed a steady erosion of its pharmaceutical job base and has been rocked by a series of mergers within one of its largest employment bases.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

GlobeSt

Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2024 ALM Global, LLC. All Rights Reserved.